PTC Therapeutics, Inc. (PTCT)
71.06
+1.24
(+1.78%)
USD |
NASDAQ |
Aug 24, 16:00
71.02
-0.04
(-0.06%)
After-Hours: 20:00
PTC Therapeutics 1 Year Total Returns (Daily) : 40.52% for Aug. 24, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 24, 2026 | 40.52% |
| August 21, 2026 | 42.72% |
| August 20, 2026 | 44.36% |
| August 19, 2026 | 48.56% |
| August 18, 2026 | 45.84% |
| August 17, 2026 | 49.28% |
| August 14, 2026 | 47.23% |
| August 13, 2026 | 49.41% |
| August 12, 2026 | 60.46% |
| August 11, 2026 | 70.21% |
| August 10, 2026 | 64.46% |
| August 07, 2026 | 45.57% |
| August 06, 2026 | 37.95% |
| August 05, 2026 | 35.41% |
| August 04, 2026 | 32.25% |
| August 03, 2026 | 30.66% |
| July 31, 2026 | 30.51% |
| July 30, 2026 | 48.25% |
| July 29, 2026 | 51.13% |
| July 28, 2026 | 70.03% |
| July 27, 2026 | 69.42% |
| July 24, 2026 | 65.85% |
| July 23, 2026 | 66.63% |
| July 22, 2026 | 69.00% |
| July 21, 2026 | 64.02% |
| Date | Value |
|---|---|
| July 20, 2026 | 63.78% |
| July 17, 2026 | 61.94% |
| July 16, 2026 | 63.11% |
| July 15, 2026 | 65.11% |
| July 14, 2026 | 57.82% |
| July 13, 2026 | 67.52% |
| July 10, 2026 | 71.34% |
| July 09, 2026 | 83.73% |
| July 08, 2026 | 85.88% |
| July 07, 2026 | 85.91% |
| July 06, 2026 | 74.12% |
| July 02, 2026 | 69.50% |
| July 01, 2026 | 67.42% |
| June 30, 2026 | 67.01% |
| June 29, 2026 | 63.66% |
| June 26, 2026 | 70.39% |
| June 25, 2026 | 72.86% |
| June 24, 2026 | 70.11% |
| June 23, 2026 | 65.58% |
| June 22, 2026 | 61.27% |
| June 18, 2026 | 56.61% |
| June 17, 2026 | 54.43% |
| June 16, 2026 | 41.26% |
| June 15, 2026 | 49.77% |
| June 12, 2026 | 47.39% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Insmed, Inc. | -5.99% |
| Madrigal Pharmaceuticals, Inc. | 23.46% |
| Protagonist Therapeutics, Inc. | 169.2% |
| Biogen, Inc. | 56.57% |
| BioMarin Pharmaceutical, Inc. | 11.08% |